middle.news
How Did Acrux Double Revenue and Return to Profit in H1 FY26?
10:22am on Wednesday 25th of February, 2026 AEDT
•
Healthcare
Read Story
How Did Acrux Double Revenue and Return to Profit in H1 FY26?
10:22am on Wednesday 25th of February, 2026 AEDT
Key Points
Revenue surges 109% to $3.573 million
Net profit of $165,000 after prior period loss
Divestment of underperforming Prilocaine/Lidocaine cream
Expansion of licensing agreements, including Saudi Arabia
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ACRUX (ASX:ACR)
OPEN ARTICLE